Somatic GATA1 mutations drive the development of transient abnormal myelopoiesis (TAM; also known as transient myeloproliferative disorder [TMD]) in utero through impaired megakaryocytic differentiation (Roy et al. 2009; Bhatnagar et al. 2016). This evidence concerns the gene GATA1 and transient myeloproliferative syndrome.